[go: up one dir, main page]

WO2009148229A3 - Immunogenic peptide and composition containing the peptide for preventing or treating hpv-related diseases - Google Patents

Immunogenic peptide and composition containing the peptide for preventing or treating hpv-related diseases Download PDF

Info

Publication number
WO2009148229A3
WO2009148229A3 PCT/KR2009/002713 KR2009002713W WO2009148229A3 WO 2009148229 A3 WO2009148229 A3 WO 2009148229A3 KR 2009002713 W KR2009002713 W KR 2009002713W WO 2009148229 A3 WO2009148229 A3 WO 2009148229A3
Authority
WO
WIPO (PCT)
Prior art keywords
peptide
preventing
composition containing
related diseases
treating hpv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2009/002713
Other languages
French (fr)
Korean (ko)
Other versions
WO2009148229A2 (en
Inventor
이경률
임종백
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocore Co Ltd
Original Assignee
Biocore Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocore Co Ltd filed Critical Biocore Co Ltd
Publication of WO2009148229A2 publication Critical patent/WO2009148229A2/en
Publication of WO2009148229A3 publication Critical patent/WO2009148229A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to an immunogenic peptide and a composition containing the peptide for preventing or treating HPV-related diseases, and more particularly, to an E7 immunogenic peptide derived from an HPV type 16 E7 protein and to a composition containing the peptide for preventing or treating HPV-related diseases.
PCT/KR2009/002713 2008-06-02 2009-05-22 Immunogenic peptide and composition containing the peptide for preventing or treating hpv-related diseases Ceased WO2009148229A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2008-0051833 2008-06-02
KR1020080051833A KR20090125629A (en) 2008-06-02 2008-06-02 Immune peptides and compositions for preventing or treating HPP-related diseases comprising the peptides

Publications (2)

Publication Number Publication Date
WO2009148229A2 WO2009148229A2 (en) 2009-12-10
WO2009148229A3 true WO2009148229A3 (en) 2010-03-04

Family

ID=41398643

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/002713 Ceased WO2009148229A2 (en) 2008-06-02 2009-05-22 Immunogenic peptide and composition containing the peptide for preventing or treating hpv-related diseases

Country Status (2)

Country Link
KR (1) KR20090125629A (en)
WO (1) WO2009148229A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL291537B2 (en) 2016-06-20 2023-11-01 Isa Pharmaceuticals B V Formulation of a peptide vaccine
MA46354A (en) 2016-10-03 2019-08-07 Juno Therapeutics Inc MOLECULES BINDING SPECIFICALLY TO HPV
CA3042703A1 (en) * 2016-11-07 2018-05-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Development of agonist epitopes of the human papillomavirus
EP3692063A1 (en) 2017-10-03 2020-08-12 Juno Therapeutics, Inc. Hpv-specific binding molecules
MX2020010460A (en) 2018-04-05 2021-01-29 Juno Therapeutics Inc T-CELL RECEPTORS, AND ENGINEERED CELLS EXPRESSING THEM.
WO2024223299A2 (en) 2023-04-26 2024-10-31 Isa Pharmaceuticals B.V. Methods of treating cancer by administering immunogenic compositions and a pd-1 inhibitor

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060079453A1 (en) * 2002-10-03 2006-04-13 John Sidney Hla binding peptides and their uses
WO2009120022A2 (en) * 2008-03-28 2009-10-01 바이오코아 주식회사 Immunopeptide, and a composition for the prophylaxis or treatment of hpv-related medical conditions comprising the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060079453A1 (en) * 2002-10-03 2006-04-13 John Sidney Hla binding peptides and their uses
WO2009120022A2 (en) * 2008-03-28 2009-10-01 바이오코아 주식회사 Immunopeptide, and a composition for the prophylaxis or treatment of hpv-related medical conditions comprising the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SARAH A. COMERFORD ET AL.: "Identification ofT- and B-Cell Epitopes of the E7 Protein of Human Papillomavirus Type 16", JOURNAL OF VIROLOGY, vol. 65, no. 9, September 1991 (1991-09-01), pages 4681 - 4690 *

Also Published As

Publication number Publication date
WO2009148229A2 (en) 2009-12-10
KR20090125629A (en) 2009-12-07

Similar Documents

Publication Publication Date Title
WO2009059325A3 (en) Multitype hpv peptide compositions and methods for treatment or prevention of human papillomavirus infection
WO2007087384A3 (en) Methods for modulating mannose content of recombinant proteins
EP2455459A3 (en) Lipase variants for pharmaceutical use
WO2006036916A3 (en) Rnai modulation of apob and uses thereof
EP2428222A3 (en) Vaccine peptide combinations against cat allergy
SG10201407640PA (en) Hepatitis b virus specific antibody and uses thereof
WO2008127364A3 (en) Antiviral compounds and use thereof
WO2008028117A3 (en) Glp-2 mimetibodies, polypeptides, compositions, methods and uses
WO2011017132A3 (en) Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
WO2009148229A3 (en) Immunogenic peptide and composition containing the peptide for preventing or treating hpv-related diseases
WO2009004593A3 (en) Processes for the preparation of epinephrine
WO2011157447A3 (en) Modified parvovirus having enhanced anti-tumour efficacy
WO2007130616A3 (en) Polyamides for treating human papilloma virus
WO2009148230A3 (en) Immunogenic peptide and composition containing the peptide for preventing or treating hpv-related diseases
WO2012075015A3 (en) Oral metronidazole pharmaceutical compositions
IL210538A0 (en) Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunuity
WO2011098778A3 (en) Peptides for vaccines against birch allergy
WO2010046061A3 (en) Cosmetic and/or pharmaceutical formulations
WO2007103584A3 (en) Polyamides for treating human papilloma virus
WO2010098583A2 (en) Novel method for preparing statin compounds or salts thereof, and intermediate compounds used in same
WO2010057242A3 (en) Vaccine
WO2009120022A3 (en) Immunopeptide, and a composition for the prophylaxis or treatment of hpv-related medical conditions comprising the same
WO2008033556A3 (en) High pressure treatment of proteins for reduced immunogenicity
WO2007014077A3 (en) Rnai modulation of the rho-a gene and uses thereof
WO2009158238A3 (en) Fibroblast growth factor (fgf) analogs and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09758482

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09758482

Country of ref document: EP

Kind code of ref document: A2